Circuit analysis of NMDAR hypofunction in the hippocampus, in vitro, and psychosis of schizophrenia

Hippocampus

Volumn 11, Issue 5, 2001, Pages 569-577

  Greene, Robert ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

EPSC; Glycine; Ketamine; NMDA antagonist; Place cell

Indexed keywords

EXCITATORY AMINO ACID; GLUTAMIC ACID; KETAMINE; N ACETYLASPARTYLGLUTAMIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; PEPTIDE; PHENCYCLIDINE;

ANESTHESIA; ANIMAL TISSUE; ARTICLE; ASSOCIATION; BRAIN CORTEX; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG MECHANISM; HIPPOCAMPUS; HUMAN; IN VITRO STUDY; INFORMATION PROCESSING; INTERNEURON; LEARNING; LONG TERM POTENTIATION; MODEL; NONHUMAN; PRIORITY JOURNAL; PSYCHOSIS; RAT; RECEPTOR BLOCKING; SCHIZOPHRENIA; SYNAPTIC TRANSMISSION;

EXCITATORY POSTSYNAPTIC POTENTIALS; HIPPOCAMPUS; HUMANS; NEURAL PATHWAYS; RECEPTORS, N-METHYL-D-ASPARTATE; SCHIZOPHRENIA;

EID: 0035189088     PISSN: 10509631     EISSN: None     Source Type: Journal    
DOI: 10.1002/hipo.1072     Document Type: Article

References (66)

1. Modulation of the inputoutput function of rat piriform cortex pyramidal cells
2. The immunochemical localization of N-acetylaspartyl glutamate, its hydrolysing enzyme NAALADASE, and the NMDAR-1 receptor at a vertebrate neuromuscular junction
3. Modulation of N-methyl-D-aspartate receptor function by glycine transport
4. Conservation of hippocampal memory function in rats and humans
5. Tonic facilitation of glutamate release by presynaptic N-methyl-D-aspartate autoreceptors in the entorhinal cortex
6. N-acetylaspartyglutamate selectively inhibits neuronal responses to N-methyl-D-aspartic acid in vitro
7. Abnormal hippocampal spatial representations in alphaCaMKIIT286A and CREBalphaDelta-mice
8. Synaptic activation of N-Methyl-D-aspartate receptors in the Schaffer collaterol-commissural pathway of rat hippocampus
9. The nagging question of the function of N-acetylaspartylglutamate
10. The glutamate receptor ion channels
11. Co-localization of N-acetyl-aspartyl-glutamate in central cholinergic, noradrenergic, and serotonergic neurons
12. Interneurons of the hippocampus
13. Dose finding trial of D-cycloserine added to neuroleptics for negative symptoms in schizophrenia
14. NMDA-dependent modulation of CA1 local circuit inhibition
15. Quantitation of N-acetyl-aspartyl-aspartyl-glutamate in microdissected rat brain nuclei and peripheral tissues: Findings with a novel liquid phase immunoassay
16. Cloning expression and localization of a rat brain high affinity glycine transporter
17. Neuromodulation and cortical function: Modeling the physiological basis of behavior
18. Block of N-methyl-D-aspartate-activated current by the anticonvulsant MK-801: Selective binding to open channels
19. Proteomic analysis of NMDA receptor-adhesion protein signaling complexes
20. Recent advances in the phencyclidine model of schizophrenia
21. Amelioration of negative symptoms in schizophrenia by glycine
22. Glycine potentiates the NMDA response in cultured mouse brain neurons
23. Abolition of long-term stability of new hippocampal place cell maps by NMDA receptor blockade
24. Functional consequences of reduction in NMDA receptor glycine affinity in mice carrying targeted point mutations in the glycine binding site
25. Requirement for glycine in activation of NMDA receptors expressed in Xenopus oocytes
26. N-acetyl-aspartyl-glutamate: Regional levels in rat brain and the effects of brain lesions as determined by a new HPLC method
27. Molecular effects of the psychotropic NMDA receptor antagonist MK-801 in the rat entorhinal cortex: Increases in AP-1 DNA binding activity and expression of Fos and Jun family members
28. Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans
29. Cloning and expression of glycine transporter from mouse brain
30. Cloning and expression of a spinal cord- and brain-specific glycine transporter with novel structural features
31. Actions of ketanine, phencyclidine and MK-801 on NMDA receptor currents in cultured mouse hippocampal neurons
32. Studies of the interrelationship between cerebrospinal fluid and plasma amino acid concentrations in normal individuals
33. Impaired hippocampal representation of space in CA1-specific NMDAR1 knockout mice
34. Differential distribution of N-acetyl-aspartylglutamate
35. Comparative distribution of N-acetylaspartylglutamate and GAD67 in the cerebellum and precerebellar nuclei of the rat utilizing enhanced carbodiimide fixation and immunohistochemistry
36. Developmental and regional expression in the rat brain and functional properties of four NMDA receptors
37. Alternative splicing generates functionally distinct N-methyl-D-aspartate receptors
38. The hippocampal slice: A system for studying the pharmacology of seizures and for screening anticonvulsant drugs
39. Pathological changes induced in cerebrocortical neurons by phencyclidine and related drugs
40. NMDA receptor hypofunction model of schizophrenia
41. Neurochemical and immunocytochemical studies on the distribution of N-acetylaspartyglutamate and N-acetyl-aspartate in rat spinal cord and some peripheral nervous tissues
42. Schizophrenics show spatial working memory deficits
43. Distribution of N-acetylaspartylglutamate immunoreactivity in human brain and its alteration in neurodegenerative disease
44. Modification of seizure activity by electrical stimulation. I. After-discharge threshold
45. Hydrolysis of the brain dipeptide N-acetyl-L-aspartyl-L-glutamate. Identification and characterization of a novel N-acetylated alpha-linked acidic dipeptidase activity from rat brain
46. Heteromeric NMDA receptors: Molecular and functional distinction of subtypes
47. Low concentration N-acetylaspartylglutamate suppresses the climbing fiber response of Purkinje cells in guinea pig cerebellar slices and the response to excitatory amino acids of Xenopus laevis oocytes injected with cerebellar mRNA
48. N-acetylaspartylglutamate acts on an agonist upon homomeric NMDA receptor (NMDARI expressed in Xenopus oocytes)
49. Competitive inhibition of N-acetylated-alpha linked acidic dipeptidase activity by N-acetyl-L aspartyl-beta-lined glutamate
50. Abnormalities of the left temporal lobe and thought disorder in schizophrenia. A quantitative magnetic resonance imaging study
51. Rat brain N-acetylated alpha linked acidic dipeptidase activity. Purification and immunologic characterization
52. Molecular heterogeneity of the gamma-aminobutyric acid (GABA) transport system. Cloning of two novel high affinity GABA transporters from rat brain
53. Hippocampal neuron responses to selective activation of recurrent collaterals of hippocampofugal axons
54. The effects of N-acetylated alpha-linked acidic dipeptidase (NAALADase) inhibitors on [3H]NAAG catabolism in vivo
55. Delay-dependent impairment of a matching to place task with chronic and intrahippocampal infusiion of the NMDA-antagonist D-AP5
56. Induction of cAMP response element modulator (CREM) and inducible cAMP early repressor (ICER) expression in rat brain by uncompetitive N-methyl-D-aspartate receptor antagonists
57. Effect of removal on n-acetylaspartylglutamate immunoreactivity in retinal target cells
58. N-acetylglutamate immuno-reactivity in neurons of the monkey's visual pathway
59. Synaptic and intrinsic conductances shape picrotoxin-induced synchronized after-discharges in the guinea-pig hippocampal slice
60. Excitatory synaptic transmission in cultures of rat olfactory bulb
61. Excitatory actions of NMDA receptor antagonists in rat entorhinal cortex and cultured entorhinal cortical neurons
62. High concentrations of N-acetyleaspartylglutamate (NAAG) selectively activates NMDA receptors on mouse spinal cord neurons in cell culture
63. 14C-2-deoxyglucose uptake and Fos immunocytochemistry
64. Calcium-dependent release of N-acetyl-asparity glutamate from retinal neurons upon depolarization
65. Volume of parahippocampal gyrus and hippocampus in schizophrenia
66. N-acetylaspartylglutamate: Possible role as the neurotransmitter of the lateral olfactory tract